Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 13.6B | 13.6B | 13.2B | 12.9B |
| Cost of revenue | 3.2B | 3.3B | 3.2B | 3.2B |
| Gross profit | 10.4B | 10.2B | 9.9B | 9.7B |
| Operating expense | ||||
| Research & development | 2.4B | 2.8B | 2.4B | 2.4B |
| Selling general and admin | 3.1B | 3.5B | 3.1B | 3.1B |
| Other operating expenses | 306M | 361M | 785M | 227M |
| Operating income | 4.7B | 3.5B | 3.6B | 4.0B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 270M | 275M | 264M | 246M |
| Other income expense | -3M | -183M | -4M | -2M |
| Pretax income | 4.4B | 3.3B | 3.4B | 3.8B |
| Tax provision | 798M | 465M | 200M | 595M |
| Net income | 3.6B | 2.8B | 3.2B | 3.2B |
| Basic EPS | 3.7 | 2.8 | 3.2 | 3.2 |
| Diluted EPS | 3.6 | 2.8 | 3.1 | 3.2 |
| Basic average shares | 984M | 993.5M | 1.0B | 1.0B |
| Diluted average shares | 989.5M | 1.0B | 1.0B | 1.0B |
| EBITDA | 5.8B | 5.2B | 5.6B | 5.2B |
| Net income from continuing op. | 3.6B | 2.8B | 3.2B | 3.2B |
| Minority interests | -3M | -2M | 4M | 0 |
| Preferred stock dividends | — | — | — | — |